📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
520 announcements match the current filters (relevance ≥ 5).
Bajaj Healthcare Shareholders Approve Re-appointment of CMD and 6 Other Directors
Bajaj Healthcare Limited has successfully passed seven special resolutions via postal ballot as of February 19, 2026. Key approvals include the re-appointment of Mr. Sajankumar Rameshwarlal Bajaj as Chairman & Managing Director and Mr. Anil Champalal Jain as Managing Director. The company also appointed three new Non-Executive Independent Directors to its board. While all resolutions passed with the requisite majority, Resolution 7 faced significant dissent from public institutional voters.
Key Highlights
Re-appointment of Sajankumar Rameshwarlal Bajaj as CMD passed with 99.99% of total votes in favor.
Three new Independent Directors (Mr. Vaghela, Mrs. Amin, and Mr. Bhavsar) were officially inducted into the board.
Total of 19.3 million votes were polled, representing 61.13% of the total outstanding shares.
Resolution 7 regarding the re-appointment of Mr. Pakshal Anil Jain saw 99.99% of voting public institutions (599,840 votes) voting against.
All 7 resolutions were special resolutions and passed with the required majority as per SEBI regulations.
👀 What to Watch
The approval ensures management continuity, which is generally stable for the stock. However, investors should monitor the reasons behind the high institutional dissent on Resolution 7 to evaluate any underlying corporate governance concerns.
Waaree Energies Clarifies ₹8,175 Crore Battery Giga-Factory News and Expansion Plans
Waaree Energies has clarified news reports regarding a proposed ₹8,175 crore battery giga-factory investment in Andhra Pradesh. The company confirmed that its Board had previously approved a capacity expansion from 3.5 GWh to 20 GWh for Lithium-Ion cells and Battery Energy Storage Systems (BESS) in October 2025. This expansion involves a capital expenditure of approximately ₹8,000 crores through its subsidiary, Waaree Energy Storage Solutions. While discussions with the Andhra Pradesh government and other states are ongoing for a greenfield facility, no new material development beyond the 2025 disclosure has occurred.
Key Highlights
Confirmed planned capacity expansion from 3.5 GWh to 20 GWh for Lithium-Ion cells and BESS
Allocated capital expenditure of approximately ₹8,000 crores for the expansion project
Actively in discussions with the Government of Andhra Pradesh and other states for a greenfield facility
Expansion is being executed through wholly owned subsidiary Waaree Energy Storage Solutions Private Limited
The ₹8,000 crore capex plan was originally approved by the Board on October 01, 2025
👀 What to Watch
Investors should view the confirmation of the massive ₹8,000 crore capex as a long-term growth driver in the energy storage space. Monitor for official MoUs with state governments which will provide clarity on project timelines and incentives.
Hindware Home Innovation Q3 FY26: EBITDA Jumps 38% to ₹52 Cr; Roorkee Plant Commences Operations
Hindware Home Innovation reported a steady Q3 FY26 with consolidated revenue growing 8% YoY to ₹640 crore and EBITDA rising 38% to ₹52 crore. The Bathware segment saw 14% revenue growth driven by premiumization, with premium products now contributing 40% of its revenue. The company is strategically discontinuing loss-making consumer categories like fans and air purifiers to focus on high-margin kitchen appliances, targeting a segment revenue of ₹650-700 crore by FY31. While the Pipes business faced resin price volatility, the new Roorkee plant is expected to add ₹200 crore in annual revenue once fully ramped up.
Key Highlights
Consolidated Q3 FY26 EBITDA grew 38% YoY to ₹52 crore with margins improving from 6% to 8%.
Bathware segment revenue increased 14% YoY to ₹386 crore, supported by a 5-day improvement in working capital cycles.
Strategic exit from loss-making categories (fans, air purifiers, furniture fittings) to focus on kitchen appliances and water heaters.
Roorkee Pipes plant commenced commercial production in Jan 2026, targeting ₹200 crore incremental annual revenue.
9M FY26 PBT before exceptional items turned positive at ₹30 crore compared to a loss of ₹30 crore in the previous year.
👀 What to Watch
Investors should view the strategic rationalization of the consumer portfolio and the commencement of the Roorkee plant as positive catalysts for margin expansion. Monitor the execution of the premiumization strategy in Bathware and the stabilization of resin prices in the Pipes segment.
Amara Raja Q3 FY26: Revenue Up 4.2% to ₹3,410 Cr; New Energy Segment Revenue Doubles
Amara Raja Energy & Mobility reported a consolidated revenue of INR 3,410 crores for Q3 FY26, a 4.2% YoY growth. While the lead-acid business remains the primary driver, the New Energy segment crossed the INR 200 crore milestone, doubling its revenue compared to the previous year. The company faced headwinds in exports, which declined 15%, and telecom lead-acid volumes, which fell over 45% due to lithium transition. To counter raw material cost pressures, a 2% price hike was implemented in January 2026, and the board approved a new 5 GWh BESS plant with a ₹280 crore outlay.
Key Highlights
Consolidated revenue reached INR 3,410 crores with 4-wheeler OEM volumes growing 25% YoY.
New Energy business revenue doubled YoY to over INR 200 crores, driven by telecom lithium pack demand.
Board approved a 5 GWh integrated BESS plant with INR 280 crore investment, expected operational by FY27-end.
Standalone operating margins were 11.2%, but adjusted for recycling efficiencies and trading, margins stood at 12.3%.
YTD December capex stood at INR 950 crores, with FY27 New Energy capex projected at INR 1,000 crores.
👀 What to Watch
Investors should focus on the company's aggressive transition toward New Energy and BESS solutions as lead-acid telecom demand fades. Monitor the margin recovery in Q4 following the January price hike and the progress of the lithium cell subsidiary investments.
Amara Raja Q3 FY26 Revenue Up 4.2% to ₹3,410 Cr; New Energy Business Doubles
Amara Raja Energy & Mobility reported a consolidated revenue of ₹3,410 crores for Q3 FY26, supported by a robust 25% growth in 4-wheeler OEM volumes. The New Energy segment reached a milestone of ₹200 crores in quarterly revenue, doubling year-on-year, while lead-acid battery margins remained resilient at 12% on an adjusted basis. However, overall growth was tempered by a 15% decline in exports and a significant 45% drop in lead-acid telecom volumes as the market shifts toward lithium solutions. The company is aggressively pivoting with a newly approved ₹280 crore BESS plant and a planned ₹1,000 crore New Energy capex for FY27.
Key Highlights
Consolidated revenue grew 4.2% YoY to ₹3,410 crores, with New Energy revenue crossing the ₹200 crore mark for the first time.
4-wheeler OEM volumes surged 25%, though aftermarket growth was modest at 3% and exports declined by 15% due to geopolitical issues.
Board approved a 5 GWh integrated BESS plant with an outlay of ₹280 crores, targeting operational status by end of FY27.
Standalone operating margin stood at 11.2%, impacted by rising costs of tin alloys and sulfuric acid, leading to a 2% price hike in January 2026.
Total investment in the lithium subsidiary has reached ₹1,400 crores, with YTD December total capex at ₹950 crores.
👀 What to Watch
Investors should focus on the company's successful transition toward lithium and BESS segments which are showing high growth, despite margin pressures in the core lead-acid business. Monitor the execution of the high-capex New Energy projects as they will determine long-term valuation re-rating.
Religare Enterprises Reports Q3 FY26 Net Loss of ₹76.5 Cr; Care Health GWP Grows to ₹7,906 Cr
Religare Enterprises Limited (REL) reported a consolidated net loss of ₹76.5 crore for Q3 FY26, compared to a loss of ₹63.2 crore in the same period last year. While total income grew by 23.8% YoY to ₹2,067.9 crore, rising expenses and higher claims in the insurance segment weighed on profitability. Care Health Insurance remains the primary growth engine, contributing ₹7,906 crore in GWP for 9M FY26 with a 22% market share in the SAHI segment. The company's NBFC arm, Religare Finvest, is now debt-free with over ₹500 crore in cash reserves following successful NPA recoveries.
Key Highlights
Consolidated Total Income increased 23.8% YoY to ₹2,067.9 crore in Q3 FY26.
Care Health Insurance GWP grew to ₹7,906 crore for 9M FY26, up from ₹6,508 crore YoY.
Consolidated Net Loss for 9M FY26 stood at ₹22.5 crore versus a profit of ₹32 crore in 9M FY25.
Care Health's AUM crossed a significant milestone, reaching ₹10,246 crore as of December 2025.
Religare Finvest (NBFC) has resolved legacy issues and maintains a cash balance of ₹500+ crore.
👀 What to Watch
Investors should focus on the improving operational metrics of Care Health and the debt-free status of the NBFC arm, while remaining cautious about the widening consolidated losses. Monitor the combined ratio in the insurance business, which rose to 111.1% in Q3 FY26, as a key indicator of future profitability.
Religare Enterprises Announces Strategic Demerger of Financial Services; 1:1 Share Swap Ratio
Religare Enterprises (REL) has approved a demerger to separate its financial services and insurance businesses into two independent listed entities. The financial services business, including lending and broking, will be transferred to Religare Finvest Limited (RFL), while REL will retain the insurance business through Care Health Insurance. Shareholders will receive 1 share of RFL for every 1 share held in REL. The demerged undertaking contributed ₹457.29 crore (6.2%) to the consolidated turnover in FY25.
Key Highlights
Demerger of lending, broking, and investment activities into Religare Finvest Limited (RFL)
Shareholders to receive 1 fully paid-up equity share of RFL for every 1 share held in REL
Demerged business accounted for ₹457.29 crore (6.2%) of FY25 consolidated turnover
REL to remain an insurance-focused entity holding the stake in Care Health Insurance Limited
RFL to be listed on BSE and NSE with a target completion date in Q1 FY28
👀 What to Watch
Investors should maintain their positions to benefit from the value unlocking of two distinct business platforms. Monitor the progress of regulatory approvals from the RBI and NCLT, as these are critical for the Q1 FY28 listing timeline.
Religare Enterprises Announces 1:1 Demerger of Financial Services Business into Religare Finvest
Religare Enterprises (REL) has approved a scheme to demerge its financial services, broking, and investment businesses into its subsidiary, Religare Finvest Limited (RFL). Shareholders will receive one equity share of RFL for every one share held in REL, with RFL set to be listed on both BSE and NSE. The demerged undertaking contributed INR 457.29 Crores, or 6.2% of the total consolidated turnover, in FY25. Post-demerger, REL will focus on its insurance business through Care Health Insurance, while RFL will operate as an independent lending and broking entity.
Key Highlights
Shareholders to receive 1 share of Religare Finvest for every 1 share held in Religare Enterprises.
Demerged financial services division reported a turnover of INR 457.29 Crores (6.2% of total) in FY25.
Religare Enterprises will retain its core investment and shareholding in Care Health Insurance Limited.
Religare Finvest (RFL) is expected to be listed on BSE and NSE by Q1 FY28.
The scheme involves a 100% mirror-image shareholding pattern for the new listed entity.
👀 What to Watch
Investors should maintain their positions to benefit from the value unlocking of two distinct listed entities. However, note the long implementation timeline with listing expected only by Q1 FY28.
Religare Enterprises Reports Q3 FY26 Standalone Net Loss of ₹11.31 Crore
Religare Enterprises reported a standalone net loss of ₹1,131.19 lakhs for the quarter ended December 31, 2025, a significant increase from the ₹397.38 lakhs loss reported in the previous quarter. Total income for the quarter plummeted to ₹238.61 lakhs from ₹759.58 lakhs in Q2 FY26, largely due to a sharp reduction in 'Other Income'. Expenses rose to ₹1,381.50 lakhs, primarily driven by employee benefit costs which more than doubled to ₹848.95 lakhs. The company continues to face ongoing income tax litigations, as noted by the statutory auditors in their limited review report.
Key Highlights
Standalone net loss widened to ₹11.31 crore in Q3 FY26 compared to a loss of ₹3.97 crore in Q2 FY26.
Total income declined by 68.6% quarter-on-quarter to ₹2.39 crore.
Employee benefit expenses surged to ₹8.49 crore from ₹3.38 crore in the preceding quarter.
The company reported a negative Earnings Per Share (EPS) of ₹0.34 for the quarter.
Auditors included an 'Emphasis of Matter' regarding ongoing income tax litigations and related demands.
👀 What to Watch
Investors should exercise caution as the standalone entity's losses are widening and operational expenses are rising. The focus should remain on the performance of its underlying subsidiaries in insurance and broking, as well as the resolution of legal and tax contingencies.
MT Educare Reports Q3 FY26 Net Loss of ₹1.87 Crore Amid Ongoing Insolvency Process
MT Educare Limited reported a net loss of ₹187.15 lakhs for the quarter ended December 31, 2025, which narrowed from a loss of ₹363.94 lakhs in the same quarter last year. Revenue from operations saw a significant jump to ₹244.97 lakhs compared to ₹98.23 lakhs year-on-year. The company remains under the Corporate Insolvency Resolution Process (CIRP) since December 2022, and the statutory auditors have issued a 'Disclaimer of Conclusion' on these results. This disclaimer indicates that the auditors were unable to obtain sufficient evidence to verify the carrying amounts of assets, liabilities, and the overall impact of the insolvency proceedings.
Key Highlights
Revenue from operations increased to ₹244.97 lakhs in Q3 FY26 from ₹98.23 lakhs in Q3 FY25.
Net loss for the quarter stood at ₹187.15 lakhs, showing improvement over the ₹363.94 lakhs loss in the previous year's corresponding period.
Statutory auditors issued a Disclaimer of Conclusion due to non-availability of balance confirmations and non-determination of fair value for financial assets.
The company did not recognize interest expenses of ₹87.55 lakhs for the quarter on defaulted bank borrowings.
Management did not account for interest income of ₹573.09 lakhs for the quarter on long-outstanding overdue loans.
👀 What to Watch
Investors should remain highly cautious as the company is undergoing insolvency proceedings and the financial results are not fully verifiable by auditors. There is a significant risk of capital erosion depending on the final resolution plan approved by the NCLT.
Hindware Home Innovation Q3 FY26: Revenue up 7.7% to ₹640 Cr, Returns to Profitability
Hindware Home Innovation reported a consolidated revenue of ₹640.08 crore for Q3 FY26, marking a 7.7% YoY growth. The company successfully turned profitable in its continuing operations with a net profit of ₹3.69 crore, a significant recovery from the ₹16.94 crore loss in Q3 FY25. The results were impacted by a strategic decision to exit high-loss consumer appliance categories, leading to a net exceptional charge of ₹44.28 crore for the nine-month period. The core Building Products segment continues to perform steadily, contributing nearly 87% of the total revenue.
Key Highlights
Q3 Consolidated Revenue rose to ₹640.08 crore compared to ₹594.23 crore in the previous year.
Net Profit for continuing operations stood at ₹3.69 crore vs a loss of ₹16.94 crore YoY.
Building Products segment revenue grew to ₹558.71 crore from ₹526.88 crore YoY.
9M FY26 performance includes a ₹44.28 crore exceptional loss related to the exit from non-core consumer categories.
Restructuring via a Composite Scheme of Arrangement is underway to streamline business operations.
👀 What to Watch
The return to quarterly profitability and the exit from loss-making segments are positive structural changes. Investors should monitor the progress of the pending demerger and amalgamation scheme for long-term value unlocking.
Hindware Home Innovation Q3 FY26 Revenue Grows 6% YoY to ₹559 Cr; Bathware Leads Growth
Hindware Home Innovation reported a 6% YoY increase in Q3 FY26 revenue to ₹559 crore, primarily driven by a strong 14% growth in the Bathware segment. However, the Pipes business (TRUFLO) faced headwinds with revenue declining 8.5% YoY to ₹173 crore and sales volumes dropping to 10,327 MT. The company is currently undergoing a major corporate restructuring to demerge its consumer products business, which is pending NCLT approval. Profitability remains under pressure with a consolidated PBT margin of just 1.5% for the quarter, while net bank debt stood at ₹713 crore.
Key Highlights
Q3 FY26 consolidated revenue rose to ₹559 crore compared to ₹527 crore in Q3 FY25.
Bathware segment revenue grew 14% YoY to ₹386 crore with a stable EBITDA margin of 10%.
Pipes business revenue fell to ₹173 crore from ₹189 crore YoY, with volumes declining by 8.3%.
Commenced commercial production at the Roorkee plant on January 30, 2026, adding 12,500 tonnes of capacity.
Composite Scheme of Arrangement for demerger and separate listing of entities is currently with NCLT Kolkata.
👀 What to Watch
Investors should monitor the execution of the corporate restructuring which aims to unlock value by listing two separate entities. While Bathware shows resilience, the recovery of volumes in the Pipes segment and overall margin improvement are critical for a positive re-rating.
Hindware Home Innovation Q3 Results: Turnaround to ₹3.69 Cr Profit; Revenue Up 7.7% YoY
Hindware Home Innovation reported a consolidated net profit of ₹3.69 crore for Q3 FY26, marking a significant recovery from a net loss of ₹16.94 crore in the previous year's corresponding quarter. Revenue from operations grew by 7.7% YoY to ₹640.08 crore, supported by steady growth in the Building Products segment. The company is actively streamlining operations by exiting high-loss consumer categories like air coolers and fans to focus on core kitchen appliances. A major corporate restructuring involving a demerger and amalgamation is currently awaiting NCLT approval.
Key Highlights
Consolidated revenue rose 7.7% YoY to ₹640.08 crore in Q3 FY26 compared to ₹594.23 crore in Q3 FY25.
Reported a net profit of ₹3.69 crore, turning around from a net loss of ₹16.94 crore in the year-ago period.
EBITDA grew significantly to ₹51.57 crore from ₹37.49 crore in the same period last year.
Building Products segment revenue increased to ₹558.71 crore from ₹526.88 crore YoY.
Exceptional items include a ₹4.65 crore impact from new labor codes and adjustments for discontinued product categories.
👀 What to Watch
The return to profitability and strategic exit from loss-making segments are encouraging signs for long-term margin improvement. Investors should monitor the progress of the NCLT-led corporate restructuring scheme which aims to simplify the business structure.
Amara Raja Q3 FY26: 9M Revenue Hits INR 1 Lakh Cr; New 5 GWh BESS Giga Factory Announced
Amara Raja Energy & Mobility (ARE&M) reported a standalone revenue of INR 1,00,889 million for 9M FY26 with an EBITDA margin of 11.6%. The company is accelerating its transition to New Energy, announcing a 5 GWh Battery Energy Storage System (BESS) Giga Factory with a capex of INR 280 crores. The lithium pack business for telecom reached a significant milestone of INR 200 crores in quarterly revenue, while the traditional 4W OEM lead-acid segment maintained double-digit growth. Strategic investments continue with a INR 200 crore infusion into its subsidiary ARACT for advanced cell manufacturing.
Key Highlights
9M FY26 Standalone Revenue reached INR 1,00,889 Mn with EBITDA of INR 11,671 Mn.
Announced 5 GWh BESS Giga Factory with INR 280 Cr capex, targeting operations by FY28.
New Energy telecom packs crossed INR 200 Cr revenue milestone with 80%+ capacity utilization.
Infused INR 200 Cr into subsidiary ARACT; 16 GWh Giga-cell plant construction is underway.
Lead recycling refinery operations commenced in Dec 2024, with battery breaking expected in Q4 FY26.
👀 What to Watch
Investors should focus on the company's successful scale-up of the lithium pack business and the progress of the Giga-cell factory as it pivots toward energy transition. The core lead-acid business remains a stable cash generator, supporting the aggressive INR 95 billion long-term capex plan.
Amara Raja to Incorporate US Subsidiary with $5 Million Investment for Global Expansion
Amara Raja Energy & Mobility (ARE&M) has approved the incorporation of a wholly owned subsidiary in the USA, tentatively named 'ARE&M US Inc.' The company plans to invest up to USD 5 million in this new entity through equity, loans, or capital expenditure in one or more tranches. This move is aimed at strengthening customer service capabilities, facilitating global business expansion, and establishing a local presence to evaluate future manufacturing or assembly opportunities in the US market. The incorporation process is expected to be completed within the next 3 to 6 months.
Key Highlights
Board approved a 100% wholly owned subsidiary in the USA to be incorporated within 3-6 months.
Total investment commitment of up to USD 5 million in equity, loans, or other securities.
Primary focus on battery and components distribution and improving customer service response times.
Strategic intent to evaluate future localization, including potential manufacturing or assembly in the US.
👀 What to Watch
Investors should view this as a positive step toward global diversification and potential entry into the US energy storage market. Monitor future updates regarding localization plans or larger capital commitments in the US.
Aarey Drugs & Pharmaceuticals Approves Q3 FY26 Unaudited Financial Results
Aarey Drugs & Pharmaceuticals Limited held a board meeting on February 11, 2026, to approve the unaudited financial results for the quarter ended December 31, 2025. The board confirmed the submission of the Limited Review Report and MD/CFO certifications as per SEBI regulations. The company operates in a single business segment, focusing on bulk drugs and chemical imports. While the specific profit and loss figures were not detailed in this cover letter, the results have been officially taken on record.
Key Highlights
Board approved unaudited financial results for the quarter ended December 31, 2025.
The board meeting was held on February 11, 2026, from 3:00 p.m. to 6:30 p.m.
MD and CFO provided formal certification regarding the accuracy of the financial statements.
The company confirmed it operates within a single reporting segment.
👀 What to Watch
Investors should look for the detailed financial tables on the stock exchange to evaluate revenue growth and margin performance. Monitor the company's ability to manage raw material costs in the bulk drug and solvent import business.
Amara Raja Q3 Revenue Up 6% YoY to ₹3,351 Cr; New Energy Segment Crosses ₹200 Cr Milestone
Amara Raja Energy & Mobility reported a 6% year-on-year revenue growth to ₹3,350.84 crore for Q3 FY26, supported by strong domestic automotive OEM demand. However, profitability faced significant pressure as Profit Before Tax (PBT) fell to ₹207.48 crore from ₹422.16 crore in the previous year's corresponding quarter. The New Energy business achieved a key milestone by crossing ₹200 crore in revenue, while exports were hampered by geopolitical tensions. The company remains on track for its Gigafactory commercial production by early next calendar year.
Key Highlights
Revenue from operations increased 6% YoY to ₹3,350.84 crore in Q3 FY26.
Profit before tax (PBT) declined sharply to ₹207.48 crore compared to ₹422.16 crore in Q3 FY25.
New Energy Business revenue crossed the ₹200 crore mark for the first time in a quarter.
Exports saw a decline during the period due to ongoing global geopolitical tensions.
Gigafactory commercial production remains on track for early next calendar year (2027).
👀 What to Watch
Investors should monitor the impact of geopolitical headwinds on export margins and the significant decline in PBT. While the New Energy segment's growth is a positive long-term catalyst, the current bottom-line volatility suggests a cautious approach until margins stabilize.
CARE Ratings Reports Strong Q3 FY26 Performance with 24% YoY Growth in Consolidated PAT
CARE Ratings Limited reported a robust performance for 9M FY26, with consolidated revenue from operations growing 17% YoY to Rs. 342.40 crore. Profitability saw a significant jump as consolidated PAT rose 24% YoY to Rs. 120.25 crore, driven by operational efficiencies and a 46% standalone EBITDA margin. While the ratings segment remains the core contributor at 89% of revenue, the non-ratings segment showed faster growth at 21% YoY. Despite a 11% decline in corporate bond issuances during Q3, the company benefited from a 14.5% increase in bank credit offtake.
Key Highlights
Consolidated PAT for 9M FY26 grew by 24% YoY to Rs. 120.25 crore with a 32% margin.
Consolidated revenue from operations for 9M FY26 increased 17% YoY to Rs. 342.40 crore.
Standalone EBITDA margin stood at a healthy 46% for 9M FY26, up from 44% in the previous year.
Non-ratings segment revenue grew by 21% YoY to Rs. 36.71 crore, contributing 11% to total revenue.
Bank credit offtake accelerated to 14.5% growth as of December 2025, supporting rating volumes.
👀 What to Watch
Investors should view the strong margin expansion and growth in non-rating segments as positive indicators of business diversification and efficiency. The stock remains a play on the Indian credit cycle and private capex revival, though moderation in bond issuances is a factor to watch.
Amara Raja Q3 FY26 Consolidated Net Profit Drops 53% YoY to ₹140.15 Crore
Amara Raja Energy & Mobility reported a modest 4.2% YoY growth in consolidated revenue to ₹3,410.15 crore for the quarter ended December 31, 2025. However, consolidated net profit saw a sharp decline of 53% YoY to ₹140.15 crore, significantly impacted by rising raw material costs and an exceptional charge of ₹47.63 crore related to new labour code gratuity liabilities. The company continues its capital-intensive transition toward green energy, infusing an additional ₹200 crore into its advanced cell technology subsidiary during the quarter.
Key Highlights
Consolidated Revenue from operations increased 4.2% YoY to ₹3,410.15 crore.
Consolidated Net Profit fell 53% YoY to ₹140.15 crore from ₹298.37 crore in the previous year.
Exceptional item of ₹47.63 crore recognized due to increased gratuity liability from the new Labour Codes.
Cost of materials consumed rose approximately 10% YoY to ₹2,247.13 crore, impacting operating margins.
Total investment in Amara Raja Advanced Cell Technologies reached ₹1,400.01 crore following a ₹200 crore infusion this quarter.
👀 What to Watch
Investors should monitor the margin pressure resulting from rising input costs and the heavy capital expenditure required for the new energy business. While the core battery business remains stable, the short-term profitability is likely to remain volatile during the transition to advanced cell manufacturing.
CARE Ratings Q3 Net Profit Jumps 29% YoY to ₹35.9 Crore; Revenue Up 16%
CARE Ratings reported a strong year-on-year performance for the quarter ended December 31, 2025, with consolidated net profit rising 29.1% to ₹35.9 crore. Revenue from operations grew by 16.3% YoY to ₹112.1 crore, reflecting steady demand in the credit rating and analytics business. While sequential performance showed a decline from the September quarter, the nine-month (9M FY26) net profit remains robust at ₹118.3 crore, a 25% increase over the previous year. The company continues to manage its cost base effectively despite a rise in employee benefit expenses.
Key Highlights
Consolidated Revenue from operations increased 16.3% YoY to ₹112.12 crore in Q3 FY26.
Net Profit attributable to owners grew 29.1% YoY to ₹35.90 crore from ₹27.80 crore.
9M FY26 Net Profit reached ₹118.34 crore, up 25% compared to ₹94.63 crore in 9M FY25.
Total expenses for the quarter rose to ₹76.12 crore, with employee costs accounting for ₹55.13 crore.
Other income remained a significant contributor at ₹12.99 crore for the quarter.
👀 What to Watch
Investors should view the strong year-on-year growth as a positive indicator of the company's market position. The stock remains a key beneficiary of the expanding Indian corporate bond market and credit growth.
